318 related articles for article (PubMed ID: 31787695)
21. Influenza vaccine effectiveness in older adults compared with younger adults over five seasons.
Russell K; Chung JR; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Flannery B
Vaccine; 2018 Feb; 36(10):1272-1278. PubMed ID: 29402578
[TBL] [Abstract][Full Text] [Related]
22. Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA study.
Jimenez-Jorge S; Pozo F; de Mateo S; Delgado-Sanz C; Casas I; Garcia-Cenoz M; Castilla J; Sancho R; Etxebarriarteun-Aranzabal L; Quinones C; Martinez E; Vega T; Garcia A; Gimenez J; Vanrell JM; Castrillejo D; Larrauri A;
Euro Surveill; 2014 Mar; 19(9):. PubMed ID: 24626206
[TBL] [Abstract][Full Text] [Related]
23. Influence of Birth Cohort on Effectiveness of 2015-2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States.
Flannery B; Smith C; Garten RJ; Levine MZ; Chung JR; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Murthy K; Zimmerman R; Nowalk MP; Griffin MR; Keipp Talbot H; Treanor JJ; Wentworth DE; Fry AM
J Infect Dis; 2018 Jun; 218(2):189-196. PubMed ID: 29361005
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of influenza vaccine in children in preventing influenza associated hospitalisation, 2018/19, England.
Pebody RG; Zhao H; Whitaker HJ; Ellis J; Donati M; Zambon M; Andrews N
Vaccine; 2020 Jan; 38(2):158-164. PubMed ID: 31648914
[TBL] [Abstract][Full Text] [Related]
25. A mid-term estimate of 2018/2019 vaccine effectiveness to prevent laboratory confirmed A(H1N1)pdm09 and A(H3N2) influenza cases in Sicily (Italy).
Costantino C; Restivo V; Amodio E; Colomba GME; Vitale F; Tramuto F
Vaccine; 2019 Sep; 37(39):5812-5816. PubMed ID: 31427134
[TBL] [Abstract][Full Text] [Related]
26. Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008.
Fielding JE; Grant KA; Papadakis G; Kelly HA
BMC Infect Dis; 2011 Jun; 11():170. PubMed ID: 21669006
[TBL] [Abstract][Full Text] [Related]
27. Association of Prior Vaccination With Influenza Vaccine Effectiveness in Children Receiving Live Attenuated or Inactivated Vaccine.
McLean HQ; Caspard H; Griffin MR; Gaglani M; Peters TR; Poehling KA; Ambrose CS; Belongia EA
JAMA Netw Open; 2018 Oct; 1(6):e183742. PubMed ID: 30646262
[TBL] [Abstract][Full Text] [Related]
28. Influenza vaccine effectiveness in Italy: Age, subtype-specific and vaccine type estimates 2014/15 season.
Rizzo C; Bella A; Alfonsi V; Puzelli S; Palmieri AP; Chironna M; Pariani E; Piatti A; Tiberti D; Ghisetti V; Rangoni R; Colucci ME; Affanni P; Germinario C; Castrucci MR
Vaccine; 2016 Jun; 34(27):3102-3108. PubMed ID: 27154392
[TBL] [Abstract][Full Text] [Related]
29. Influenza vaccine effectiveness in preventing hospitalizations with laboratory-confirmed influenza in Greece during the 2014-2015 season: A test-negative study.
Lytras T; Kossyvakis A; Melidou A; Andreopoulou A; Exindari M; Gioula G; Kalliaropoulos A; Tryfinopoulou K; Pogka V; Spala G; Malisiovas N; Mentis A
J Med Virol; 2016 Nov; 88(11):1896-904. PubMed ID: 27088266
[TBL] [Abstract][Full Text] [Related]
30. Spread of Antigenically Drifted Influenza A(H3N2) Viruses and Vaccine Effectiveness in the United States During the 2018-2019 Season.
Flannery B; Kondor RJG; Chung JR; Gaglani M; Reis M; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Kim SS; Blanton L; Kniss K; Budd AP; Brammer L; Stark TJ; Barnes JR; Wentworth DE; Fry AM; Patel M
J Infect Dis; 2020 Jan; 221(1):8-15. PubMed ID: 31665373
[TBL] [Abstract][Full Text] [Related]
31. Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses.
Skowronski DM; Janjua NZ; De Serres G; Sabaiduc S; Eshaghi A; Dickinson JA; Fonseca K; Winter AL; Gubbay JB; Krajden M; Petric M; Charest H; Bastien N; Kwindt TL; Mahmud SM; Van Caeseele P; Li Y
PLoS One; 2014; 9(3):e92153. PubMed ID: 24667168
[TBL] [Abstract][Full Text] [Related]
32. On field vaccine effectiveness in three periods of 2018/2019 influenza season in Emilia-Romagna Region.
Colucci ME; Veronesi L; Bracchi MT; Zoni R; Caruso L; Capobianco E; Rossi D; Bizzarro A; Cantarelli A; Affanni P
Acta Biomed; 2019 Sep; 90(9-S):21-27. PubMed ID: 31517886
[TBL] [Abstract][Full Text] [Related]
33. Pooled influenza vaccine effectiveness estimates for Australia, 2012-2014.
Sullivan SG; Carville KS; Chilver M; Fielding JE; Grant KA; Kelly H; Levy A; Stocks NP; Tempone SS; Regan AK
Epidemiol Infect; 2016 Aug; 144(11):2317-28. PubMed ID: 27125368
[TBL] [Abstract][Full Text] [Related]
34. The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness.
Zhang L; Pan Y; Hackert V; van der Hoek W; Meijer A; Krafft T; Yang P; Wang Q
Vaccine; 2018 Aug; 36(33):4993-5001. PubMed ID: 30017144
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of Live Attenuated vs Inactivated Influenza Vaccines in Children During the 2012-2013 Through 2015-2016 Influenza Seasons in Alberta, Canada: A Canadian Immunization Research Network (CIRN) Study.
Buchan SA; Booth S; Scott AN; Simmonds KA; Svenson LW; Drews SJ; Russell ML; Crowcroft NS; Loeb M; Warshawsky BF; Kwong JC
JAMA Pediatr; 2018 Sep; 172(9):e181514. PubMed ID: 29971427
[TBL] [Abstract][Full Text] [Related]
36. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season.
Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M
Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661
[TBL] [Abstract][Full Text] [Related]
37. 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals.
Rondy M; Launay O; Puig-Barberà J; Gefenaite G; Castilla J; de Gaetano Donati K; Galtier F; Hak E; Guevara M; Costanzo S; ; Moren A
Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613779
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results.
Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R
Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051
[TBL] [Abstract][Full Text] [Related]
39. Estimating vaccine effectiveness against laboratory-confirmed influenza among children and adolescents in Lower Saxony and Saxony-Anhalt, 2012-2016.
Möhl A; Gräfe L; Helmeke C; Ziehm D; Monazahian M; Irmscher HM; Dreesman J
Epidemiol Infect; 2018 Jan; 146(1):78-88. PubMed ID: 29208075
[TBL] [Abstract][Full Text] [Related]
40. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.
Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y
J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
